Skip to main content
. 2024 Dec 19;7(12):e2450489. doi: 10.1001/jamanetworkopen.2024.50489

Table 1. Cohort Characteristics.

Characteristic Patients, No. (%) (N = 1929)
Age at diagnosis, ya
Mean (SD) 28 (8)
Median (IQR) 30 (23-35)
Sexa
Female 1049 (54.5)
Male 875 (45.5)
Race
American Indian or Alaska Native 5 (0.3)
Asian 227 (11.8)
Black or African American 157 (8.1)
Native Hawaiian or Other Pacific Islander 14 (0.7)
White 1184 (61.4)
More than 1 race 11 (0.6)
Not documented 293 (15.2)
Otherb 38 (2.0)
Ethnicity
Hispanic or Latino 514 (26.6)
Not Hispanic or Latino 762 (39.5)
Not documented 653 (33.9)
Primary cancer sitea
Bone or soft tissue 264 (13.7)
Brain 170 (8.8)
Breast 265 (13.8)
Gastrointestinal tract 369 (19.2)
Genitourinary tract 214 (11.1)
Head, neck, or thyroid 72 (3.7)
Leukemia 164 (8.5)
Lung 85 (4.4)
Lymphoma 119 (6.2)
Melanoma or skin 67 (3.5)
Other 136 (7.1)
Stage at diagnosisa
I-III 1119 (67.6)
IV 537 (32.4)
Site of care
DFCI 703 (36.4)
KPNC 526 (27.3)
KPSC 700 (36.3)

Abbreviations: DFCI, Dana-Farber Cancer Institute; KPNC, Kaiser Permanente Northern California; KPSC, Kaiser Permanente Southern California.

a

Missing data: age at cancer diagnosis, n = 37; sex, n = 5; primary cancer site, n = 4; stage, n = 273.

b

Other races included declined to state and unknown.